VelocityTX Vital Signs
One day she defended her dissertation. The next, she sat down for hot wings and answered questions that would make even the most seasoned biotech execs sweat. In this episode of Vital Signs, Dr. Paulomi Modi [https://www.linkedin.com/in/paulomimodi/] talks rhabdomyosarcoma therapy resistance, why pediatric oncology needs smarter commercialization pathways, how Nucleate Texas [https://www.linkedin.com/company/nucleate-texas/] is helping students turn science into startups, and what San Antonio can do to strengthen its life science ecosystem without losing what makes it unique. Her take: San Antonio does not need to become someone else’s biotech scene. We need to double down on what already works here, build the missing infrastructure, and give founders the support to move from great science to real clinical impact.
7 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de VelocityTX Vital Signs!